Alk Positive Nsclc Clinical Trials

ReadTheTrial indexes 1 studies for Alk Positive Nsclc. The most common development stage is Phase 1 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Alk Positive Nsclc.

Pipeline by Phase

PhaseTrialsDistribution
Phase 1 1
100%

Trial Status Breakdown

Trials for Alk Positive Nsclc

A Multi-center, Open-label Study to Assess the Safety and Efficacy of Combination Ceritinib (LDK378) and Nivolumab in Adult Patients With Anaplastic Lymphoma Kinase (ALK)-Positive Non-small Cell Lung Cancer (NSCLC)

NCT02393625 · ACTIVE NOT RECRUITING · Phase 1

Frequently Asked Questions

What clinical trials are available for Alk Positive Nsclc?

There are 1 clinical trials listed for Alk Positive Nsclc. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Alk Positive Nsclc trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Alk Positive Nsclc trials in?

Current Alk Positive Nsclc trials are distributed across: Phase 1 (1).

Find More Trials